Expression of TP53 isoforms p53β or p53γ enhances chemosensitivity in TP53(null) cell lines.
The carboxy-terminal truncated p53 alternative spliced isoforms, p53β and p53γ, are expressed at disparate levels in cancer and are suggested to influence treatment response and therapy outcome. However, their functional role in cancer remains to be elucidated. We investigated their individual funct...
Guardado en:
Autores principales: | Elisabeth Silden, Sigrun M Hjelle, Line Wergeland, André Sulen, Vibeke Andresen, Jean-Christophe Bourdon, David R Micklem, Emmet McCormack, Bjørn Tore Gjertsen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/14b0caf52b21424191e729f001e39752 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
TP53 in Myelodysplastic Syndromes
por: Yan Jiang, et al.
Publicado: (2021) -
Comprehensive Identification of Deleterious <i>TP53</i> Missense VUS Variants Based on Their Impact on TP53 Structural Stability
por: Benjamin Tam, et al.
Publicado: (2021) -
<i>TP53</i> Combined Phenotype Score Is Associated with the Clinical Outcome of <i>TP53</i>-Mutated Myelodysplastic Syndromes
por: Mariko Yabe, et al.
Publicado: (2021) -
DOR/Tp53inp2 and Tp53inp1 constitute a metazoan gene family encoding dual regulators of autophagy and transcription.
por: Ana Sancho, et al.
Publicado: (2012) -
Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil.
por: Juliana Giacomazzi, et al.
Publicado: (2014)